QO'SHMA TERAPİYANI O'RGANISH SAVOLiga AKUSHARLIKDA ANTIFOSFOLIPID SINDROMNI BOSHQARISH VA GINEKOLOGIYA

Mualliflar

  • Хасанхон Мамадалиев Kokand Universiteti Andijon filiali

Kalit so‘zlar:

антифосфолипидный синдром, беременность, акушерство, гинекология, комбинированная терапия, антикогулянты, репродуктивные потери, иммунотерапия.

Abstrak

Antifosfolipid sindromi (APS) kasallikning asosiy sabablaridan biridir
akusherlik va ginekologiyada trombotik asoratlar va reproduktiv yo'qotishlar
amaliyot. Ushbu maqolada reproduktiv yoshdagi ayollarda APS kursining xususiyatlari ko'rib chiqiladi va ulardan foydalanishning maqsadga muvofiqligi asoslanadi.
antikoagulyantlar, antiplatelet agentlari va qo'shilishi bilan kombinatsiyalangan terapiya
immunotrop moddalar. Bemorlarni davolashda zamonaviy yondashuvlarni tahlil qilish
Homiladorlik davrida APS va kontseptsiyani rejalashtirish amalga oshiriladi, zarurat tug'iladi
akusherlikni kamaytirish uchun terapiyaga individual yondashuv
perinatal asoratlar ta'kidlangan. Akusherlikda APSni kompleks davolashni optimallashtirish sohasida keyingi tadqiqotlar istiqbollari va
ginekologiya taqdim etiladi.

References

Science journals portal+1Хеликс СПб+1

Медицинский Журнал+1Хеликс СПб+1

Science journals portal+3rmj.ru+3Здоров’я України+3Хеликс СПб+3Здоров’я України+3Science journals portal+3

https://pubmed.ncbi.nlm.nih.gov/11953980// Cervera R., Piette J.C. et al. (2002). "Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients." Arthritis Rheum

https://journals.sagepub.com/doi/abs/10.1177/0961203309106832, Giannakopoulos B., Krilis S.A. (2013). "The pathogenesis of the antiphospholipid syndrome." New England Journal of Medicine.

Miyakis S. et al. (2006). "International consensus statement on an update of the classification criteria for definite APS." J Thromb Haemost; Urbanus R.T., Derksen R.H.W.M., de Groot P.G. (2009). "Current insight into the pathophysiology of the antiphospholipid syndrome." Blood

Erkan D., Lockshin M.D. (2002). "Management of the antiphospholipid syndrome." New England Journal of Medicine; Tektonidou M.G. et al. (2020). "EULAR recommendations for the management of antiphospholipid syndrome in adults." Annals of the Rheumatic Diseases.

Pengo V. et al. (2020). "Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome." Blood; Meroni P.L., Borghi M.O. (2019). "New therapies for APS: are we there yet?" Nature Reviews Rheumatology.

Science journals portal+3rmj.ru+3Здоров’я України+3Хеликс СПб+2Здоров’я України+2thrj.ru+2Дополнительная литература:

Трофимов Е.А., Трофимова А.С. Антифосфолипидный синдром: особенности течения у беременных и варианты терапии. РМЖ. 2016;15:923–926.

Куташов В.А. Основные принципы лечения антифосфолипидного синдрома. Прикладные информационные аспекты медицины.

Downloads

Nashr qilingan

2025-06-16

Nashr

Jild 2 Nomeri 4.5 (2025): FARMASEVTIKA, BIOTEXNOLOGIYA VA BIOTIBBIYOTDA ZAMONAVIY TADQIQOTLAR VA ILMIY YANGILIKLAR” mavzusidagi xalqaro ilmiy-amaliy konferensiya Andijon. 23-24 aprel 2025-yil

Bo'lim

Maqolalar

License

Copyright (c) 2025 Хасанхон Мамадалиев

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

QO’SHMA TERAPİYANI O’RGANISH SAVOLiga AKUSHARLIKDA ANTIFOSFOLIPID SINDROMNI BOSHQARISH VA GINEKOLOGIYA. (2025). Universal Xalqaro Ilmiy Jurnal, 2(4.5), 573-578. https://universaljurnal.uz/index.php/jurnal/article/view/2515